Skip Ribbon Commands
Skip to main content
Calcium Metabolism and Osteoporosis Program







  • IOF One-minute Osteoporosis Risk Test

    Are you among the one in three women, and the one in five men over the age of 50 who will be affected by osteoporosis in their lifetimes?
    Osteoporosis weakens bones and leads to fractures.
    It causes severe disability.
    But osteoporosis can be detected early.
    It can be treated .
    If you knew something that could harm you was coming, wouldn't you avoid it?
  • New Educational Material from IOF for WOD


World Osteoporosis Day-TBS Trial License

World Osteoporosis Day-Patient Brochure

News and Events


- Dr. Ghada El-Hajj Fuleihan was selected as recipient of the 2017 Harvard T. Chan School of Public Health Award of Merit. This recognition was delivered at Harvard T. Chan School of Public Health, at the School’s Alumni annual meeting, that took place on Saturday October 14th, Boston, MA. The Award of Merit is the highest School honor recognizing extraordinary achievements of select alumni  (View)  (Honorees)  (Photos)

- Dr. Maya Barake-paper entitled "Effects of Growth Hormone Therapy on Bone Density and Fracture Risk in Age-Related Osteoporosis in the Absence of Growth Hormone Deficiency. A Systematic Review and Meta-Analysis" has been accepted for publication in Endocrine.

- Presidential Symposium - Women at AUB: Strategic Institutional Initiatives (View) (Video)


- Dr. El-Hajj Fuleihan appointed as Chair, Clinical Science Program, for the Endocrine Society’s 101th Annual Meeting and Expo- ENDO 2019, that will be held in New Orleans, USA

- The Endocrine Society has selected Dr Marlene Chakhtoura to receive the 2017 Early Investigators Award. This award assists in the development of early career investigators and recognition of their accomplishments in areas of diabetes and metabolic bone. (about the award) (Read)


- Experts make the case for European vitamin D fortification strategy (Read)

- Restoring the Art of Medicine (Read)

- New guidelines- Comparative Analysis of Nutritional Guidelines for Vitamin D, by Dr. Roger Bouillion were published in Nature Reviews (View)

- FDA approves Radius Health’s Tymlos(abaloparatide), a bone building agent for the treatment of postmenopausal women with osteoporosis at high risk for fracture (View)


- The North American Menopause Society (NAMS) updates the 2012 Hormone Therapy Position Statement and identifies future research needs (View)

- Vitamin D Trial at AUBMC Leading the News in Endocrine Society' Newsletter (View)

Osteoporosis Health Facts




Contact us Jobs Disclaimer Copyright Non-Discrimination/Title IX